Main Content

Press Release
WKR: Elekta's share redemption program concluded

ELEKTA'S SHARE REDEMPTIONPROGRAM CONCLUDED

On November 11, 2003, theacceptance period for Elekta's offer for redemption of sharesexpired.

The offer involved redemption ofevery seventeenth share held in Elekta at a price of SEK 165 pershare.

Based on the final count, 1,887,713shares were tendered for redemption, corresponding to 97.4percent of the maximum number of shares that could be redeemed inaccordance with the offer. Approx. SEK 311.5 million will thus betransferred to Elekta's shareholders.

Payment of the redemption amountis expected to be made at the end of March 2004. This is causedby the fact that under Swedish law, when a company decides toredeem shares by reducing the share capital, the decision may notbe effected without the permission of a Swedish court.

It is estimated that the court’spermission will be obtained within 3-4 months from the end of theapplication period and that payment of the redemption proceedswill occur as soon as reasonably practicable after the court’spermission has gained legal force.

For further information, pleasecontact:
International: Peter Ejemyr, Group VP CorporateCommunications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com

United States: Lars Jonsteg, VPInvestor Relations North America, Elekta, USA
Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.com

About Elekta:
Elekta is a world-leading supplier of advanced andinnovative radiation oncology and neurosurgery solutions andservices for precise treatment of cancer and brain disorders.Elekta's solutions are clinically effective, cost efficient andgentle to the patient.

For additional informationabout Elekta, please visit www.elekta.com


This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download: